Molecular Biology Reports

, Volume 39, Issue 3, pp 2471-2479

First online:

DNA repair genes polymorphism (XPG and XRCC1) and association of prostate cancer in a north Indian population

  • Nega BerhaneAffiliated withDepartment of Biotechnology, University of Gondar Email author 
  • , Rabinder Chandera SobtiAffiliated withDepartment of Biotechnology, Panjab University
  • , Salih Abdul MahdiAffiliated withDepartment of Biotechnology, Panjab University

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Prostate cancer is the most commonly diagnosed cancer in men worldwide and is the second leading cause of cancer related mortality. Genetic background may account for the difference in susceptibility of individuals to different diseases and the relationship between genetic polymorphism and some diseases has been extensively studied. There are several common polymorphisms in genes encoding DNA repair enzymes, some of these polymorphisms are reported to result in subtle structural alterations of the repair enzyme and modulation of the repair capacity. The aim of the present study was to analyze the effect of XPG Asp 1104His and XRCC1 Arg309Gln polymorphisms on risk of prostate cancer in north Indian population. Statistically significant increased risk of prostate cancer was observed on individuals that posses His/His genotype of XPG (OR 2.53, 95% CI 0.99–6.56, P = 0.031). In this study 150 prostate cancer diagnosed patients, 150 healthy controls and 150 BPH (benign prostate hyper plasia) were recruited from north Indian population. Moreover, individuals that carried the Gln/Gln genotype of XRCC1 also showed statistically increased risk of prostate cancer (OR 2.06, 95% CI 1.07–4.00, P = 0.033). The Asp/Asp of XPG and Gln/Gln of XRCC1 in combination showed statistically increased risk of prostate cancer in cases (OR 3.29, 95% CI 1.09–10.16, P = 0.032).


Prostate cancer Benign hyper plasia Polymorphism XPG XRCC1